Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.420
-0.230 (-8.68%)
At close: Jun 27, 2025, 4:00 PM
2.400
-0.020 (-0.83%)
After-hours: Jun 27, 2025, 7:58 PM EDT
Prime Medicine Market Cap
Prime Medicine has a market cap or net worth of $309.33 million as of June 27, 2025. Its market cap has decreased by -63.94% in one year.
Market Cap
309.33M
Enterprise Value
286.22M
1-Year Change
-63.94%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since the IPO on October 20, 2022, Prime Medicine's market cap has decreased from $1.63B to $309.33M, a decrease of -80.99%. That is a compound annual growth rate of -46.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 309.33M | -16.98% |
| Dec 31, 2024 | 372.58M | -54.41% |
| Dec 29, 2023 | 817.15M | -49.22% |
| Dec 30, 2022 | 1.61B | -1.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.30B |
| Johnson & Johnson | 367.07B |
| AbbVie | 331.02B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.55B |
| Abbott Laboratories | 233.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |